Position history for LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA's holdings in REGENERON PHARMACEUTICALS
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds 72,430 shares of REGN (REGENERON PHARMACEUTICALS), worth $54.2M as of 2026-Q1. The position was decreased (-16.7% shares). REGN represents 0.5% of LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA's portfolio.
Current Value
$54.2M
Current Shares
72,430
Total Value Change
-$59.3M
Total Shares Change
-31,250
Other major holders of REGN: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 72,430 |
-16.7% |
| $54.2M |
| 0.5% |
| $766.66 |
0 |
| 2025-Q4 | Decreased | 86,975 | -5.2% | $67.1M | 0.6% | $773.94 | 0 |
| 2025-Q3 | Decreased | 91,727 | -8.2% | $52.8M | 0.5% | $560.05 | 0 |
| 2025-Q2 | Increased | 99,913 | +3.6% | $52.5M | 0.5% | $519.56 | 36 |
| 2025-Q1 | Decreased | 96,473 | -9.1% | $56.7M | 0.6% | $634.66 | 0 |
| 2024-Q4 | Decreased | 106,091 | -3.1% | $72.6M | 0.6% | $698.71 | 0 |
| 2024-Q3 | Increased | 109,481 | +5.6% | $101.7M | 0.9% | $1,036.94 | 45 |
| 2024-Q2 | Increased | 103,680 | +18.8% | $113.5M | 1.0% | $1,045.23 | 56 |